Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alejandro Ruiz

Showing results (251-260 of 271) with videos related to

Pageof 28
Sort By:
Acta Haematologica|May 18, 2017
A Feasibility Study of the Full Outpatient Conduction of Hematopoietic Transplants in Persons with Multiple Sclerosis Employing Autologous Non-Cryopreserved Peripheral Blood Stem CellsGuillermo J Ruiz-Argüelles, Andrés A León-Peña, Mónica León-González, et al.
Neurosurgical Review|August 19, 2022
Somatostatin analogues in treatment-refractory meningioma: a systematic review with meta-analysis of individual patient dataLasse Rehné Jensen, Andrea Daniela Maier, Atle Lomstein, et al.
JCO Precision Oncology|January 7, 2022
EGFR Inhibitors Plus Bevacizumab are Superior Than EGFR Inhibitors Alone as First-Line Setting in Advanced NSCLC With EGFR Mutations and BIM Deletion Polymorphisms (BIM-CLICaP)Andrés F Cardona, Camila Ordóñez-Reyes, Alejandro Ruiz-Patiño, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|August 17, 2021
Characterization of the emerging B.1.621 variant of interest of SARS-CoV-2Katherine Laiton-Donato, Carlos Franco-Muñoz, Diego A Álvarez-Díaz, et al.
Cancer Treatment and Research Communications|September 26, 2025
Clinicogenomic and treatment outcomes in RET fusion-positive NSCLC: A multicenter study in Latin American Hispanic patientsOscar Arrieta, Andrés F Cardona, Nicolle Wagner-Gutiérrez, et al.
Frontiers in Public Health|September 18, 2025
Association between daily variations in the levels of atmospheric O<sub>3</sub>, PM<sub>2.5</sub>, and NO<sub>2</sub> and the frequency of hospital visits due to respiratory diseases and hypertension in Mexico City using Generalized Additive Mixed ModelsElizabeth Vega, Alejandro Ruiz-Olivares, Yosune Miquelajauregui, et al.
EMBO Molecular Medicine|June 5, 2024
Aggregation-resistant alpha-synuclein tetramers are reduced in the blood of Parkinson's patientsLaura de Boni, Amber Wallis, Aurelia Hays Watson, et al.
Translational Oncology|November 25, 2021
p.G12C KRAS mutation prevalence in non-small cell lung cancer: Contribution from interregional variability and population substructures among HispanicsAlejandro Ruiz-Patiño, July Rodríguez, Andrés F Cardona, et al.
Journal of Neuro-Oncology|September 9, 2021
Efficacy of osimertinib plus bevacizumab in glioblastoma patients with simultaneous EGFR amplification and EGFRvIII mutationAndrés F Cardona, Daniel Jaramillo-Velásquez, Alejandro Ruiz-Patiño, et al.
Lung Cancer (Amsterdam, Netherlands)|November 16, 2018
EGFR exon 20 insertion in lung adenocarcinomas among Hispanics (geno1.2-CLICaP)Andrés F Cardona, Leonardo Rojas, Zyanya Lucia Zatarain-Barrón, et al.
Pageof 28

Showing results (251-260 of 271) with videos related to

Sort By:
Pageof 28
Acta Haematologica|May 18, 2017
A Feasibility Study of the Full Outpatient Conduction of Hematopoietic Transplants in Persons with Multiple Sclerosis Employing Autologous Non-Cryopreserved Peripheral Blood Stem CellsGuillermo J Ruiz-Argüelles, Andrés A León-Peña, Mónica León-González, et al.
Neurosurgical Review|August 19, 2022
Somatostatin analogues in treatment-refractory meningioma: a systematic review with meta-analysis of individual patient dataLasse Rehné Jensen, Andrea Daniela Maier, Atle Lomstein, et al.
JCO Precision Oncology|January 7, 2022
EGFR Inhibitors Plus Bevacizumab are Superior Than EGFR Inhibitors Alone as First-Line Setting in Advanced NSCLC With EGFR Mutations and BIM Deletion Polymorphisms (BIM-CLICaP)Andrés F Cardona, Camila Ordóñez-Reyes, Alejandro Ruiz-Patiño, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|August 17, 2021
Characterization of the emerging B.1.621 variant of interest of SARS-CoV-2Katherine Laiton-Donato, Carlos Franco-Muñoz, Diego A Álvarez-Díaz, et al.
Cancer Treatment and Research Communications|September 26, 2025
Clinicogenomic and treatment outcomes in RET fusion-positive NSCLC: A multicenter study in Latin American Hispanic patientsOscar Arrieta, Andrés F Cardona, Nicolle Wagner-Gutiérrez, et al.
Frontiers in Public Health|September 18, 2025
Association between daily variations in the levels of atmospheric O<sub>3</sub>, PM<sub>2.5</sub>, and NO<sub>2</sub> and the frequency of hospital visits due to respiratory diseases and hypertension in Mexico City using Generalized Additive Mixed ModelsElizabeth Vega, Alejandro Ruiz-Olivares, Yosune Miquelajauregui, et al.
EMBO Molecular Medicine|June 5, 2024
Aggregation-resistant alpha-synuclein tetramers are reduced in the blood of Parkinson's patientsLaura de Boni, Amber Wallis, Aurelia Hays Watson, et al.
Translational Oncology|November 25, 2021
p.G12C KRAS mutation prevalence in non-small cell lung cancer: Contribution from interregional variability and population substructures among HispanicsAlejandro Ruiz-Patiño, July Rodríguez, Andrés F Cardona, et al.
Journal of Neuro-Oncology|September 9, 2021
Efficacy of osimertinib plus bevacizumab in glioblastoma patients with simultaneous EGFR amplification and EGFRvIII mutationAndrés F Cardona, Daniel Jaramillo-Velásquez, Alejandro Ruiz-Patiño, et al.
Lung Cancer (Amsterdam, Netherlands)|November 16, 2018
EGFR exon 20 insertion in lung adenocarcinomas among Hispanics (geno1.2-CLICaP)Andrés F Cardona, Leonardo Rojas, Zyanya Lucia Zatarain-Barrón, et al.
Pageof 28